All Stories

  1. High-Throughput Direct Mass Spectrometry-Based Metabolomics to Characterize Metabolite Fingerprints Associated with Alzheimer’s Disease Pathogenesis
  2. Intervention and Observational Trials are Complementary in Metabolomics: Diabetes and the Oral Glucose Tolerance Test
  3. New Experimental and Computational Tools for Drug Discovery: From Chemistry to Biology. Metabolomics, Pharmacokinetics, and Medicinal Chemistry. Part - IV
  4. Interlaboratory Coverage Test on Plant Food Bioactive Compounds and their Metabolites by Mass Spectrometry-Based Untargeted Metabolomics
  5. Metabolomic approaches for phospholipid analysis: advances and challenges
  6. Characterization of Metabolomic Profile Associated with Metabolic Improvement after Bariatric Surgery in Subjects with Morbid Obesity
  7. Untargeted Profiling of Concordant/Discordant Phenotypes of High Insulin Resistance and Obesity To Predict the Risk of Developing Diabetes
  8. An Overview on the Importance of Combining Complementary Analytical Platforms in Metabolomic Research
  9. Mass Spectrometry-Based Metabolomic Multiplatform for Alzheimer’s Disease Research
  10. Application of Targeted Metabolomics to Investigate Optimum Growing Conditions to Enhance Bioactive Content of Strawberry
  11. Correction to: Metabolomic Fingerprinting of Blood Samples by Direct Infusion Mass Spectrometry: Application in Alzheimer’s Disease Research
  12. Synergic effects of sugar and caffeine on insulin-mediated metabolomic alterations after an acute consumption of soft drinks
  13. Metabolomic Fingerprinting of Blood Samples by Direct Infusion Mass Spectrometry: Application in Alzheimer’s Disease Research
  14. Metabolomics in Alzheimer’s disease: The need of complementary analytical platforms for the identification of biomarkers to unravel the underlying pathology
  15. Direct infusion mass spectrometry for metabolomic phenotyping of diseases
  16. Size Fractionation of Metal Species from Serum Samples for Studying Element Biodistribution in Alzheimer’s Disease
  17. Combined proteomic and metallomic analyses in Scrobicularia plana clams to assess environmental pollution of estuarine ecosystems
  18. Medium-chain Fatty Acids as Biomarkers of Mitochondrial Dysfunction in Traumatic Brain Injury
  19. Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimer’s Disease and Mild Cognitive Impairment
  20. Investigation of the effect of genotype and agronomic conditions on metabolomic profiles of selected strawberry cultivars with different sensitivity to environmental stress
  21. High throughput multiorgan metabolomics in the APP/PS1 mouse model of Alzheimer's disease
  22. Application of metabolomics based on direct mass spectrometry analysis for the elucidation of altered metabolic pathways in serum from the APP/PS1 transgenic model of Alzheimer's disease
  23. Deciphering metabolic abnormalities associated with Alzheimer's disease in the APP/PS1 mouse model using integrated metabolomic approaches
  24. Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease
  25. Metabolomic research on the role of interleukin-4 in Alzheimer’s disease
  26. Metabolomics reveals significant impairments in the immune system of the APP/PS1 transgenic mice of Alzheimer's disease
  27. Metabolomic investigation of systemic manifestations associated with Alzheimer's disease in the APP/PS1 transgenic mouse model
  28. Application of a novel metabolomic approach based on atmospheric pressure photoionization mass spectrometry using flow injection analysis for the study of Alzheimer׳s disease
  29. Metabolomic screening of regional brain alterations in the APP/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry
  30. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease
  31. Development of a metabolomic approach based on urine samples and direct infusion mass spectrometry
  32. Metabolomic profiling of serum in the progression of Alzheimer's disease by capillary electrophoresis-mass spectrometry
  33. Using direct infusion mass spectrometry for serum metabolomics in Alzheimer’s disease
  34. Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry
  35. Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease
  36. Metabolic signatures associated with environmental pollution by metals in Doñana National Park using P. clarkii as bioindicator
  37. Homeostasis of metals in the progression of Alzheimer’s disease
  38. Characterization of metal profiles in serum during the progression of Alzheimer's disease
  39. Evolution of metallotionein isoforms complexes in hepatic cells of Mus musculus along cadmium exposure
  40. Iberian ham typification by direct infusion electrospray and photospray ionization mass spectrometry fingerprinting
  41. Metabolomic approach to Alzheimer’s disease diagnosis based on mass spectrometry